Literature DB >> 18755744

TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats.

H U De Schepper1, B Y De Winter, L Van Nassauw, J-P Timmermans, A G Herman, P A Pelckmans, J G De Man.   

Abstract

Patients with inflammatory bowel disease often suffer from gastrointestinal motility and sensitivity disorders. The aim of the current study was to investigate the role of transient receptor potential of the vanilloid type 1 (TRPV1) receptors in the pathophysiology of colitis-induced pelvic afferent nerve sensitization. Trinitrobenzene sulphate (TNBS) colitis (7.5 mg, 30% ethanol) was induced in Wistar rats 72 h prior to the experiment. Single-fibre recordings were made from pelvic nerve afferents in the decentralized S1 dorsal root. Fibres responding to colorectal distension (CRD) were identified in controls and rats with TNBS colitis. The effect of the TRPV1 antagonist N-(4-tertiarybutylphenyl)-4-(3-chlorophyridin-2-yl)tetrahydropyrazine-1(2H)carboxamide (BCTC; 0.25-5 mg kg(-1)) or its vehicle (hydroxypropyl-beta-cyclodextrin) was tested on the afferent response to repetitive distensions (60 mmHg). Immunocytochemical staining of TRPV1 and NF200, a marker for A-fibre neurons, was performed in the dorsal root ganglia L6-S1. TNBS colitis significantly increased the response to colorectal distension of pelvic afferent C-fibres. BCTC did not significantly affect the C-fibre response in controls, but normalized the sensitized response in rats with colitis. TNBS colitis increased the spontaneous activity of C-fibres, an effect which was insensitive to administration of BCTC. TNBS colitis had no effect on Adelta-fibres, nor was their activity modulated by BCTC. TNBS colitis caused an immunocytochemical up-regulation of TRPV1 receptors in the cell bodies of pelvic afferent NF200 negative neurons. TRPV1 signalling mediates the colitis-induced sensitization of pelvic afferent C-fibres to CRD, while Adelta-fibres are neither sensitized by colitis nor affected by TRPV1 inhibition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755744      PMCID: PMC2652143          DOI: 10.1113/jphysiol.2008.159731

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  42 in total

Review 1.  Visceral pain-peripheral sensitisation.

Authors:  G F Gebhart
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  The pharmacology of gastrointestinal nociceptive pathways.

Authors:  L A Blackshaw; G F Gebhart
Journal:  Curr Opin Pharmacol       Date:  2002-12       Impact factor: 5.547

3.  The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.

Authors:  John Winston; Mohan Shenoy; Dylan Medley; Ashutosh Naniwadekar; Pankaj Jay Pasricha
Journal:  Gastroenterology       Date:  2006-11-10       Impact factor: 22.682

4.  Estrous cycle phase variations in visceromotor and cardiovascular responses to colonic distension in the anesthetized rat.

Authors:  S Sapsed-Byrne; D Ma; D Ridout; A Holdcroft
Journal:  Brain Res       Date:  1996-12-02       Impact factor: 3.252

5.  Effects of kappa opioids in the inflamed rat colon.

Authors:  J N Sengupta; A Snider; X Su; G F Gebhart
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

6.  Purinergic mechanisms contribute to mechanosensory transduction in the rat colorectum.

Authors:  Gregory Wynn; Weifang Rong; Zhenghua Xiang; Geoffrey Burnstock
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

7.  N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.

Authors:  Kenneth J Valenzano; Elfrida R Grant; Gang Wu; Mohamed Hachicha; Lori Schmid; Laykea Tafesse; Qun Sun; Yakov Rotshteyn; Joseph Francis; James Limberis; Shiazah Malik; Edward R Whittemore; Dianne Hodges
Journal:  J Pharmacol Exp Ther       Date:  2003-04-29       Impact factor: 4.030

Review 8.  Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.

Authors:  Pierangelo Geppetti; Marcello Trevisani
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

9.  Soma neurofilament immunoreactivity is related to cell size and fibre conduction velocity in rat primary sensory neurons.

Authors:  S N Lawson; P J Waddell
Journal:  J Physiol       Date:  1991-04       Impact factor: 5.182

10.  Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons.

Authors:  Fumimasa Amaya; Kentaro Oh-hashi; Yoshihisa Naruse; Norio Iijima; Masashi Ueda; Goshun Shimosato; Makoto Tominaga; Yoshifumi Tanaka; Masaki Tanaka
Journal:  Brain Res       Date:  2003-02-14       Impact factor: 3.252

View more
  25 in total

1.  TRPV1 fans the flames of visceral pain.

Authors:  Michael J Beyak
Journal:  J Physiol       Date:  2008-11-01       Impact factor: 5.182

Review 2.  Extrinsic primary afferent signalling in the gut.

Authors:  Simon J H Brookes; Nick J Spencer; Marcello Costa; Vladimir P Zagorodnyuk
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-26       Impact factor: 46.802

3.  Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.

Authors:  Xiao-Jun Zhang; Feung Ping Leung; Wendy Wl Hsiao; Shun Tan; Shao Li; Hong-Xi Xu; Joseph Jy Sung; Zhao-Xiang Bian
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

5.  Regulation of transient receptor potential cation channel subfamily V1 protein synthesis by the phosphoinositide 3-kinase/Akt pathway in colonic hypersensitivity.

Authors:  Shanwei Shen; Hamad W Al-Thumairy; Fiza Hashmi; Li-Ya Qiao
Journal:  Exp Neurol       Date:  2017-06-03       Impact factor: 5.330

6.  Inhibition of renin release by arachidonic acid metabolites, 12(s)-HPETE and 12-HETE: role of TRPV1 channels.

Authors:  Chaoqin Xie; Donna H Wang
Journal:  Endocrinology       Date:  2011-08-16       Impact factor: 4.736

7.  Transient receptor potential vanilloid type 1 channel (TRPV1) immunolocalization in the murine enteric nervous system is affected by the targeted C-terminal epitope of the applied antibody.

Authors:  Roeland Buckinx; Luc Van Nassauw; Leela R Avula; Katrien Alpaerts; Dirk Adriaensen; Jean-Pierre Timmermans
Journal:  J Histochem Cytochem       Date:  2013-03-12       Impact factor: 2.479

8.  Combined genetic and pharmacological inhibition of TRPV1 and P2X3 attenuates colorectal hypersensitivity and afferent sensitization.

Authors:  Michael E Kiyatkin; Bin Feng; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-08-29       Impact factor: 4.052

Review 9.  Plasticity of enteric nerve functions in the inflamed and postinflamed gut.

Authors:  G M Mawe; D S Strong; K A Sharkey
Journal:  Neurogastroenterol Motil       Date:  2009-03-11       Impact factor: 3.598

Review 10.  Purinergic mechanosensory transduction and visceral pain.

Authors:  Geoffrey Burnstock
Journal:  Mol Pain       Date:  2009-11-30       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.